Invesco’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.9M Buy
251,373
+191,365
+319% +$50.9M 0.01% 982
2025
Q4
$14.8M Sell
60,008
-6,872
-10% -$1.45M ﹤0.01% 1621
2025
Q3
$11.8M Sell
66,880
-4,008
-6% -$600K ﹤0.01% 1728
2025
Q2
$9.74M Sell
70,888
-183,598
-72% -$27M ﹤0.01% 1787
2025
Q1
$45.9M Sell
254,486
-20,709
-8% -$3.48M 0.01% 1071
2024
Q4
$43.1M Sell
275,195
-90,356
-25% -$16M 0.01% 1115
2024
Q3
$66.5M Buy
365,551
+90,474
+33% +$17.4M 0.01% 931
2024
Q2
$50.5M Buy
275,077
+185,449
+207% +$31.1M 0.01% 1006
2024
Q1
$15.9M Buy
89,628
+35,399
+65% +$4.92M ﹤0.01% 1560
2023
Q4
$6.73M Buy
54,229
+10,030
+23% +$1.11M ﹤0.01% 2072
2023
Q3
$5.13M Sell
44,199
-21,009
-32% -$2.56M ﹤0.01% 2198
2023
Q2
$7.66M Buy
65,208
+13,628
+26% +$1.39M ﹤0.01% 1992
2023
Q1
$4.13M Buy
51,580
+23,537
+84% +$1.85M ﹤0.01% 2314
2022
Q4
$2.22M Sell
28,043
-23,565
-46% -$1.75M ﹤0.01% 2603
2022
Q3
$3.6M Buy
51,608
+42,454
+464% +$3.07M ﹤0.01% 2381
2022
Q2
$600K Buy
9,154
+1,404
+18% +$87.3K ﹤0.01% 3243
2022
Q1
$515K Buy
7,750
+69
+0.9% +$4.31K ﹤0.01% 3374
2021
Q4
$538K Sell
7,681
-455
-6% -$26.5K ﹤0.01% 3358
2021
Q3
$425K Buy
8,136
+931
+13% +$55.1K ﹤0.01% 3503
2021
Q2
$489K Buy
7,205
+3,454
+92% +$241K ﹤0.01% 3432
2021
Q1
$289K Buy
+3,751
New +$273K ﹤0.01% 3566
2020
Q2
Sell
-34,701
Closed -$1.5M 3667
2020
Q1
$1.5M Sell
34,701
-47,632
-58% -$2.49M ﹤0.01% 2553
2019
Q4
$4.56M Buy
82,333
+35,123
+74% +$1.72M ﹤0.01% 2218
2019
Q3
$1.64M Buy
+47,210
New +$2.11M ﹤0.01% 2736
2019
Q1
Sell
-47,113
Closed -$979K 3762
2018
Q4
$979K Buy
+47,113
New +$986K ﹤0.01% 2991

Other funds holding KRYS